Nisa Investment Advisors’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $311 | Sell |
42
-10
| -19% | -$74 | ﹤0.01% | 2931 |
|
|
2025
Q1 | $447 | Sell |
52
-93
| -64% | -$799 | ﹤0.01% | 2822 |
|
|
2024
Q4 | $5.18K | Buy |
145
+20
| +16% | +$714 | ﹤0.01% | 2269 |
|
|
2024
Q3 | $5.92K | Sell |
125
-587
| -82% | -$27.8K | ﹤0.01% | 2192 |
|
|
2024
Q2 | $35.8K | Buy |
712
+3
| +0.4% | +$151 | ﹤0.01% | 1765 |
|
|
2024
Q1 | $79.5K | Buy |
709
+3
| +0.4% | +$336 | ﹤0.01% | 1539 |
|
|
2023
Q4 | $40.9K | Buy |
706
+584
| +479% | +$33.9K | ﹤0.01% | 1685 |
|
|
2023
Q3 | $3.87K | Buy |
122
+9
| +8% | +$285 | ﹤0.01% | 2306 |
|
|
2023
Q2 | $9.28K | Buy |
113
+89
| +371% | +$7.31K | ﹤0.01% | 2271 |
|
|
2023
Q1 | $3K | Hold |
24
| – | – | ﹤0.01% | 2288 |
|
|
2022
Q4 | $4K | Sell |
24
-4
| -14% | -$667 | ﹤0.01% | 2312 |
|
|
2022
Q3 | $5K | Buy |
28
+4
| +17% | +$714 | ﹤0.01% | 2293 |
|
|
2022
Q2 | $3K | Sell |
24
-1,924
| -99% | -$241K | ﹤0.01% | 2322 |
|
|
2022
Q1 | $194K | Buy |
1,948
+1,924
| +8,017% | +$192K | ﹤0.01% | 1385 |
|
|
2021
Q4 | $3K | Hold |
24
| – | – | ﹤0.01% | 2116 |
|
|
2021
Q3 | $6 | Sell |
24
-122
| -84% | -$31 | ﹤0.01% | 2248 |
|
|
2021
Q2 | $50 | Sell |
146
-234
| -62% | -$80 | ﹤0.01% | 1945 |
|
|
2021
Q1 | $154 | Sell |
380
-684
| -64% | -$277 | ﹤0.01% | 1565 |
|
|
2020
Q4 | $708K | Buy |
1,064
+772
| +264% | +$514K | ﹤0.01% | 1059 |
|
|
2020
Q3 | $136K | Hold |
292
| – | – | ﹤0.01% | 1436 |
|
|
2020
Q2 | $171K | Buy |
+292
| New | +$171K | ﹤0.01% | 1321 |
|